FARGO — For the first time, a woman is leading Aldevron as Jennifer Meade steps into the role of president Monday, Sept. 11. Meade succeeds Kevin Ballinger in leading the Fargo-based biotechnology ...

Shares of Danaher Corporation (DHR) jumped 5% on June 17 to close at $257.08 after the company inked a deal to acquire privately-held Aldevron in an all-cash transaction for $9.6 billion. Danaher is a ...

FARGO — Michael Chambers decided that the time has come for him to turn over the day-to-day management of the firm he co-founded 22 years ago when he was freshly graduated from North Dakota State ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

EQT has agreed to sell Aldevron to Danaher Corporation for $9.6 billion. Based in Fargo, North Dakota, Aldevron is a provider of plasmid DNA, mRNA and recombinant proteins used in vaccines, gene and ...

FARGO, N.D.--(BUSINESS WIRE)--Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President of its Research Grade nucleic acids ...

NEW YORK, BASEL, Switzerland and Fargo, N.D., June 16, 2021 /PRNewswire/ — Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Aldevron, the leading ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Medical equipment maker Danaher Corp said on Thursday it would buy privately held biotech company Aldevron in an ...

Aldevron, a maker of plasmid DNA proteins, mRNA and antibodies, unveiled plans to expand its headquarters into a 14-acre campus in Fargo, North Dakota, with the first phase of the project expected to ...

The contract service organization (CSO) Aldevron was established in 1998 to offer plasmid DNA production services for the biomanufacturing of vaccines. The company’s two founders, John Ballantyne, ...

Big one: Life science tools behemoth Danaher said yesterday it would buy Aldevron in a deal valued at $9.6 billion, marking what is undoubtedly a tremendous outcome for existing shareholders – EQT and ...